---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-019496"
form_type: "8-K"
ticker: "VERA"
cik: "0001831828"
company_name: "Vera Therapeutics, Inc."
filed_at: "2024-01-30T23:59:59+00:00"
generated_at: "2026-06-06T15:10:02.038008+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Vera Therapeutics announces $250M public offering of 8.1M shares at $31.00 per share

## Summary
- Offering of 8,064,517 shares of Class A common stock at $31.00/share; gross proceeds ~$250.0M.
- Underwriters granted 30-day option to purchase up to 1,209,677 additional shares at same price less discounts.
- Underwriters include J.P. Morgan, Cowen, and Evercore as representatives; closing expected Feb 1, 2024.
- Use of proceeds not specified in the filing; likely general corporate purposes.

## SEC filing metadata
- accession: 0001193125-24-019496
- form_type: 8-K
- ticker: VERA
- cik: 0001831828
- company_name: Vera Therapeutics, Inc.
- filed_at: 2024-01-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831828/000119312524019496/0001193125-24-019496-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831828/000119312524019496/d761446d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-019496
- JSON: https://secwatch.observer/filing/0001193125-24-019496.json
- Plain text: https://secwatch.observer/filing/0001193125-24-019496.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.